tumor necrosis factor antagonists Recently Published Documents

10.1016/j.cgh.2021.11.025 ◽

2022 ◽

Vol 20 (2) ◽

pp. e337-e338

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Letter to the editor: “No benefit of concomitant immunomodulator therapy on efficacy of biologics that are not tumor necrosis factor antagonists in patients with inflammatory bowel diseases: a meta-analysis”

10.1016/j.cgh.2021.05.037 ◽

2021 ◽

Author(s):

Aviv Pudipeddi ◽

Sudarshan Paramsothy ◽

Rupert W. Leong

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumor Necrosis ◽

Meta Analysis ◽

Letter To The Editor ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease

10.1016/j.cgh.2020.12.030 ◽

2020 ◽

Author(s):

Julien Kirchgesner ◽

Rishi J. Desai ◽

Laurent Beaugerie ◽

Sebastian Schneeweiss ◽

Seoyoung C. Kim

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Secukinumab treatment of tumor necrosis factor antagonists induced paradoxical psoriasis flares in a patient with plaque psoriasis

Dermatologic Therapy ◽

10.1111/dth.14455 ◽

2020 ◽

Vol 33 (6) ◽

Author(s):

Jianfeng Zheng ◽

Ying Li ◽

Yangfeng Ding ◽

Yunlu Gao

Keyword(s):

Tumor Necrosis Factor ◽

Plaque Psoriasis ◽

Tumor Necrosis ◽

Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis

Medicine ◽

10.1097/md.0000000000022626 ◽

2020 ◽

Vol 99 (43) ◽

pp. e22626 ◽

Cited By ~ 1

Author(s):

Miguel Santin ◽

Cristina Escrich ◽

Carles Majòs ◽

Mariona Llaberia ◽

Maria D. Grijota ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inflammatory Reactions ◽

The Central Nervous System ◽

Faculty Opinions recommendation of Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736230436.793579095 ◽

2020 ◽

Author(s):

Eduard Stange

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumor Necrosis ◽

Gut Microbes ◽

Metabolic Functions ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

S0800 Safety and Efficacy of Vedolizumab vs Tumor Necrosis Factor Antagonists in an Elderly IBD Population

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000705248.77205.de ◽

2020 ◽

Vol 115 (1) ◽

pp. S410-S410

Author(s):

C. Alex Wiles ◽

Baldeep S. Pabla ◽

Chris Slaughter ◽

Elizabeth Scoville ◽

Robin Dalal ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Safety And Efficacy ◽

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

10.1016/j.cgh.2020.02.014 ◽

2020 ◽

Vol 18 (10) ◽

pp. 2295-2304.e2 ◽

Cited By ~ 3

Author(s):

Charlotte Rose Hawkey Hedin ◽

Gina Sado ◽

Nelson Ndegwa ◽

Ellina Lytvyak ◽

Andrew Mason ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Pharmacokinetics of Tumor Necrosis Factor Antagonists

Gastroenterology ◽

10.1053/j.gastro.2020.05.040 ◽

2020 ◽

Vol 159 (1) ◽

pp. 391-393

Author(s):

Reena Khanna ◽

Jeff McCurdy ◽

Waqqas Afif

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-Analysis

10.1016/j.cgh.2020.06.071 ◽

2020 ◽

Cited By ~ 1

Author(s):

Clara Yzet ◽

Momar Diouf ◽

Siddarth Singh ◽

Franck Brazier ◽

Justine Turpin ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumor Necrosis ◽

Meta Analysis ◽

Bowel Diseases ◽

Inflammatory Bowel ◽